Excuse me, who knows the meaning of high rebate in pharmaceutical sales industry and the two-vote system? Please give an example, preferably in detail, thank you! ! !

A high rebate is a high invoice. For example, a VC injection, the purchase price of 3 yuan, the invoice of 8 yuan, is on the high side. The kickback is for the middleman. Middlemen go into 3 yuan, but many go out of 8 yuan. The profit is not only his own, but also needs to be returned to the relevant personnel. It is worth mentioning that this process may occur many times in the same sales process.

The "two-vote system" is the corresponding measure taken by the state in view of this situation. In other words, from the manufacturing enterprise to the hospital, only two invoices are allowed. In other words, the production enterprise issues an invoice to the operating enterprise, which is the first invoice. Operating enterprises invoice hospitals. This is the second invoice. This is a two-vote system.

The actual situation is very complicated. Drug sales require a large number of customer service personnel, and domestic medical institutions are scattered. This will have high requirements for operating enterprises. Coupled with the lack of corresponding e-commerce and modern logistics as the basis, the two-vote system is difficult to achieve. If the two-vote system is really enforced, it will inevitably lead to the closure of a large number of pharmaceutical enterprises, and the unemployment problem will have a great impact on the drug distribution rate and drug safety. Many medical institutions in remote places even cut off medicines. Many production enterprises will also cause inventory backlog. There will even be drug monopoly in the future, and everyone may be unhappy. Maintaining the normal and orderly operation of the huge medical security system requires a strong foundation and strong local financial strength to support it.

At present, the domestic two-vote system is being put into trial operation in some areas. More is to adopt the three-vote system, or reduce the winning bid in procurement to benefit the people.